Francois Cedric 的 Form 4 申報
Apellis Pharmaceuticals, Inc.APLS，2023/5/18 申報
- 申報編號
- 0001127602-23-016189
- 申報時間
- 2023/5/18
- 交易日
- 2023/5/16-5/17
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 8 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $257.0 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Francois CedricCIK 0001658080 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/5/16 | Common Stock | M行使選擇權取得 | +30,000 | $2.67 | +$80,100 | 304,655 | 直接 | |
| 2023/5/16 | Common Stock | S賣出處分 | −934 | $83.17F6 | −$77,680.78 | 303,721 | 直接 | |
| 2023/5/16 | Common Stock | S賣出處分 | −1,800 | $83.85F7 | −$150,930 | 301,921 | 直接 | |
| 2023/5/16 | Common Stock | S賣出處分 | −14,611 | $85.01F8 | −$1,242,081.11 | 287,310 | 直接 | |
| 2023/5/16 | Common Stock | S賣出處分 | −3,007 | $85.90F9 | −$258,301.3 | 284,303 | 直接 | |
| 2023/5/16 | Common Stock | S賣出處分 | −7,528 | $87.02F10 | −$655,086.56 | 276,775 | 直接 | |
| 2023/5/16 | Common Stock | S賣出處分 | −2,120 | $87.67F11 | −$185,860.4 | 274,655 | 直接 | |
| 2023/5/17 | Common Stock | M行使選擇權取得 | +20,000 | $2.67 | +$53,400 | 294,655 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/5/16 | Common Stock | M行使選擇權處分 | −30,000 | $0.00 | $0 | 320,000 | 直接 | |
| 2023/5/17 | Common Stock | M行使選擇權處分 | −20,000 | $0.00 | $0 | 300,000 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F6
This transaction was executed in multiple trades at prices ranging from $82.500 - $83.490. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F7
This transaction was executed in multiple trades at prices ranging from $83.500 - $84.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F8
This transaction was executed in multiple trades at prices ranging from $ $84.545 - $85.520. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F9
This transaction was executed in multiple trades at prices ranging from $85.550 - $86.540. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F10
This transaction was executed in multiple trades at prices ranging from $86.550 - $87.490. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F11
This transaction was executed in multiple trades at prices ranging from $87.570 - $87.795. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。